Notice on Convening the 2nd Extraordinary General Meeting in 2025
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Notice on Convening the 2nd Extraordinary General Meeting in 2025
Filed with SSE · · 6 pages · Chinese
Release
Kangmei Pharmaceutical Co., Ltd on 6ix
Earlier from Kangmei Pharmaceutical
- Announcement on Convening the Q3 2025 Performance Briefing
- Report for Q3 2025
- Announcement on Convening the 2025 Semi-annual Performance Briefing
- Announcement on Receipt of Compensation Payment
- 2025 Semi-annual Report
Later from Kangmei Pharmaceutical
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
- Announcement on By-election of Members of Special Committees of the Board of Directors
- Announcement on Change of Signatory Certified Public Accountant and Project Quality Control Review Partner
- Announcement on Supplementary Payment of Taxes by the Wholly-owned Subsidiary
- Announcement on Transfer of Equity and Related Assets of the Wholly-owned Subsidiary
Follow Kangmei Pharmaceutical into a list and get an email when it puts out news.
Follow Kangmei Pharmaceutical